AbbVie Inc/ US00287Y1091 /
| 6/5/2023 3:45:52 PM | Chg. +0.61 | Volume | Bid3:46:36 PM | Ask3:46:40 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 137.46USD | +0.45% | 12,698 Turnover: 895,314.76 |
136.98Bid Size: 2 | 137.42Ask Size: 2 | 243.44 bill.USD | 4.14% | 20.75 |
Fundamentals
| FY 2022 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 6.65 USD | 2.62% |
| EPS Diluted: | 6.63 USD | 2.79% |
| Revenues per Share: | 32.81 USD | 3.27% |
| Book Value per Share: | 9.77 USD | 11.95% |
| Cash Flow per Share: | 14.10 USD | 9.47% |
| Dividend per Share: | 5.71 USD | 7.53% |
| Total | in mill. | |
| Revenues: | 58,054.00 USD | 3.30% |
| Net Income: | 11,836.00 USD | 2.55% |
| Operating Cash Flow: | 24,943.00 USD | - |
| Cash and Cash Equivalents: | 9,201.00 USD | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 20.75 | 24.30 |
| P/S Ratio: | 4.21 | 4.93 |
| P/BV ratio: | 14.12 | 16.54 |
| P/CF Ratio: | 9.79 | 11.46 |
| PEG: | 7.91 | 9.26 |
| Earnings Yield: | 4.82% | 4.11% |
| Dividend Yield: | 4.14% | 3.53% |
| Market Capitalization | ||
| Market Capitalization: | 243.44 bill. USD | 285.95 bill. USD |
| Free Float Market Cap.: | - USD | - USD |
| Market Cap. / Employee: | - USD | - USD |
| Shares Outstanding: | 1.76 bill. | |
Profitability
| Gross Profit Margin: | 70.00% |
| EBIT Margin: | 31.21% |
| Net Profit Margin: | 20.39% |
| Return on Equity: | 68.47% |
| Return on Assets: | 8.53% |
Financial Strength
| Liquidity I / Cash Ratio: | 31.15% |
| Liquidity II / Quick Ratio: | 69.25% |
| Liquidity III / Current Ratio: | 96.36% |
| Debt / Equity Ratio: | 702.94% |
| Dynam. Debt / Equity Ratio: | 487.18% |
Efficiency
| Employees: | - |
| Personal Expenses / Employee: | - USD |
| Revenues / Employee: | - USD |
| Net Income / Employee: | - USD |
| Total Assets / Employee: | - USD |
| * Fiscal Year End: | 12/31/2022 |
| Accounting Standard: | US GAAP |
| Currency: | USD |